Alzheimer’s disease is one of the most serious brain disorders in the world today. It slowly damages memory, thinking, and behavior, making daily life more difficult over time.
Millions of people are affected, and the number continues to grow as the population ages. Scientists have been working for many years to understand what causes this disease and how to treat it more effectively.
One of the key problems in Alzheimer’s disease is the buildup of harmful proteins in the brain. Among these proteins, tau plays a major role. In a healthy brain, tau helps support the structure of nerve cells.
However, when tau becomes abnormal, it can form toxic clumps inside brain cells. These clumps disrupt normal cell function and eventually lead to cell death. This process is closely linked to memory loss and cognitive decline.
A new study led by researchers at the University of Southern California Stem Cell center has found a promising way to reduce this harmful tau buildup.
The research was published in the scientific journal Neuron. Instead of trying to block a key brain chemical called glutamate, the scientists discovered a new gene-based method that helps the brain clear toxic tau more safely.
Glutamate is an important chemical in the brain. It helps nerve cells communicate with each other and plays a major role in learning and memory. However, too much glutamate activity can be harmful. It can trigger stress in brain cells and lead to the buildup of toxic tau proteins. This makes glutamate a difficult target for treatment.
The research team, led by Dr. Justin Ichida at the Keck School of Medicine, explained that simply reducing glutamate is not a good solution. Lowering glutamate levels too much can cause serious side effects.
These include memory problems, trouble with movement, and even loss of consciousness. Because of these risks, scientists have been searching for safer ways to protect the brain.
Instead of blocking glutamate, the researchers focused on helping the brain remove harmful proteins. They studied tiny brain-like structures grown in the lab, known as brain organoids.
These organoids were made from stem cells taken from both healthy people and patients with diseases related to tau buildup. This allowed the scientists to observe how brain cells respond under different conditions.
When the organoids were exposed to high levels of glutamate, they showed clear signs of damage. Toxic tau built up inside the cells, and many nerve cells began to die. The same effect was also seen in mice that carried a genetic change linked to dementia. This confirmed that glutamate can drive harmful changes in both human and animal brain models.
To find a way to stop this process, the researchers looked at genes that respond to glutamate. They identified a gene called KCTD20 as an important factor. When this gene was active, tau buildup increased. However, when the researchers reduced the activity of KCTD20, the results were very different.
In both the lab-grown brain models and the mice, lowering KCTD20 levels led to a strong reduction in toxic tau. At the same time, nerve cells remained healthier, even when exposed to glutamate. This suggested that KCTD20 plays a key role in how the brain handles stress and toxic proteins.
Further experiments showed how this process works. When KCTD20 was suppressed, it activated structures inside the cell called lysosomes. Lysosomes act like a cleaning system. They break down waste materials and help remove harmful substances. In this case, the lysosomes surrounded the toxic tau proteins and cleared them out of the cells.
This discovery is important because it offers a new way to treat Alzheimer’s disease. Instead of trying to reduce glutamate, which can be risky, scientists may be able to improve the brain’s natural cleaning system. By helping cells remove toxic proteins more effectively, it may be possible to slow or prevent damage.
The researchers believe this approach could lead to new treatments in the future. Dr. Jesse Lai, one of the study’s authors, said that improving tau clearance is a promising strategy. Another researcher, Dr. Joshua Berlind, noted that this method could lead to more targeted and effective therapies for Alzheimer’s and other brain diseases.
Although the study is still at an early stage, it opens the door to exciting possibilities. Scientists will now need to develop drugs or treatments that can safely target KCTD20 or boost lysosome activity in people. If successful, this could change how doctors treat Alzheimer’s disease.
For now, this research gives hope that new and better treatments are on the way. By focusing on the brain’s natural ability to clean itself, scientists may have found a safer and smarter path to fighting one of the world’s most challenging diseases.
If you care about Alzheimer’s disease, please read studies about vitamin D deficiency linked to Alzheimer’s and dementia, and strawberries can be good defence against Alzheimer’s.
For more health information, please see recent studies about foods that reduce Alzheimer’s risk, and oral cannabis extract may help reduce Alzheimer’s symptoms.
Copyright © 2026 Knowridge Science Report. All rights reserved.
